C

Carmot Therapeutics, Inc.

38 employees

Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceuticals

Date founded

2008

Funding rounds raised

Total raised

$160M

from 19 investors over 19 rounds

C

Carmot Therapeutics, Inc. raised $150M on May 25, 2023

Investors: Willett Advisors LLC, TCG X, The Column Group, Millennium Partners and RA Capital Management, L.P.

C

Carmot Therapeutics, Inc. raised $160M on July 26, 2022

Investors: Horizons Ventures, RA Capital Management, L.P., The Column Group and Willett Advisors LLC

C

Carmot Therapeutics, Inc. raised $160M on July 26, 2022

Investors: Willett Advisors LLC, Horizons Ventures, The Column Group and RA Capital Management, L.P.

C

Carmot Therapeutics, Inc. raised $47M on September 30, 2020

Investors: Horizons Ventures and The Column Group

C

Carmot Therapeutics, Inc. raised $15M on January 17, 2018

Investors: Horizons Ventures and The Column Group

C

Carmot Therapeutics, Inc. raised $500K on July 17, 2012

Investors: The Column Group

C

Carmot Therapeutics, Inc. raised $1.5M on April 12, 2010

Investors: The Column Group

FAQ